Skip to main content

Table 3 Symptoms and time to death in patients of group 2 (low dose of antivenom)

From: Use of antivenoms for the treatment of envenomation by Elapidae snakes in Guinea, Sub-Saharan Africa

Patient

Time between bite and presentation

Clinical score on arrival

Snake species

Vials of antivenom

Associated symptoms

Outcome

8

3

4

D. viridis

2

 

Recovery H6

16

21

5

D. viridis

4

 

Recovery H6

17

11

3

 

1

 

Recovery H6

19

18

6

D. polylepis

4

Edema

Death H7

20

48

2

 

1

 

Recovery H3

26

5

5

D. viridis

4

 

Recovery H6

27

6

6

 

4

Local bleeding

Recovery H6

29

2

6

 

2

Local bleeding

Death H1

33

47

2

 

1

 

Recovery H3

37

2

1

 

2

 

Recovery H3

38

13

3

 

1

Edema

Recovery H3

53

15

1

 

1

Local bleeding and edema

Recovery H3

59

4

4

 

2

Bleeding

Recovery H3

71

10

4

 

4

Edema

Recovery H6

77

20

3

D. viridis

2

Edema

Recovery H3

87

7

5

D. viridis

6

 

Recovery H48

88

4

5

 

4

 

Recovery H24

119

3

5

D. viridis

2

 

Recovery H24

123

3

4

 

1

 

Recovery H6

124

10

5

 

2

 

Recovery H24

130

3

1

 

2

Local bleeding

Recovery H6

134

14

3

Naja sp.

4

Edema

Death H4

138

4

2

 

3

 

Recovery H6

141

2

2

D. polylepis

6

 

Death H7

148

6

4

Naja sp.

2

Edema

Recovery H12

149

1

2

N. melanoleuca

1

Local bleeding

Recovery H6

  1. H: hour after initial antivenom dose.